Cancer research
Researchers in the UK are making strides in cancer treatment, with several promising trials underway that have shown significant improvements in survival rates. Cancer Research UK is funding over 100 clinical trials, involving around 80,000 people, with a total commitment of £200m over the next five years. One of
Cancer research
A comprehensive review of 45 studies has highlighted the importance of gut microbiota in detecting and treating colorectal cancer, the second deadliest cancer globally. The research, conducted by Taipei Medical University, found that microbes such as Fusobacterium nucleatum, Bacteroides fragilis, and Parvimonas micra have strong diagnostic accuracy across populations. Techniques
Cancer research
The Metastatic Prostate Cancer pipeline has witnessed considerable growth in recent years, with numerous companies and research institutions working to develop innovative treatments. DelveInsight's report provides comprehensive insights into the Metastatic Prostate Cancer pipeline landscape, covering 80+ companies and 85+ pipeline drugs. Metastatic Prostate Cancer is a life-threatening
Cancer research
A new study conducted by researchers at Fujinomiya City General Hospital in Japan has provided valuable insights into the cost-effectiveness of various chemotherapy treatments for advanced and recurrent cervical cancer. The study, published in Frontiers in Health Services, reveals that traditional first-line platinum-based doublet chemotherapy is consistently found to be
Cancer research
Researchers at the Department of Hepatobiliary Surgery have made significant progress in understanding the complexities of biliary tract cancer, a highly aggressive form of cancer with limited therapeutic options. According to a new study, "Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies,"
Cancer research
Scientists at First Jining People's Hospital in Jining, People's Republic of China, have made a groundbreaking discovery in the fight against breast cancer. According to a recent study, a DNA tetrahedron (DT) nanostructure has been successfully used to co-deliver shikonin and CpG oligonucleotide, achieving chemoimmunotherapy of
Cancer research
Research conducted at the Institute of Cancer Research in London, UK, has shed light on the potential benefits of combining immunotherapy and radiotherapy in treating cancer. According to a recent study published in The Cancer Journal, understanding how tumors evolve in the context of the immune system could provide a
Cancer research
Researchers from Princess Margaret Cancer Centre have published the results of a phase 3 study, LEAP-008, investigating the efficacy of lenvatinib plus pembrolizumab versus docetaxel in patients with metastatic non-small cell lung cancer (NSCLC) that had progressed on anti-programmed cell death protein 1 or anti-programmed cell death ligand 1 therapy
Cancer research
A new study published in the journal Frontiers in Immunology has presented a novel approach to cancer gene therapy, leveraging the convergence of artificial intelligence (AI), nanotechnology, and personalized medicine. The research, conducted by a team of scientists from ICESI University, proposes the concept of Smart CART Nanosymbionts, an integrated
Cancer research
A recent study by researchers from the Cancer Hospital in Beijing, China, highlights the pivotal year 2024 as a significant turning point for therapeutic breakthroughs in human diseases, particularly in cell and gene therapies (CGTs). According to the study, 2024 saw the approval of 13 novel CGTs by the US
Cancer research
Research led by Tao Liu of Capital Medical University has made a groundbreaking discovery in the field of cancer gene therapy, elucidating the role of the MDM2-GPX4-ferroptosis regulatory axis in intracerebral hemorrhage. This research holds promise for identifying new therapies for this condition, which is characterized by bleeding in the
Cancer research
Dermot Murnaghan, a former Sky News presenter, has spoken publicly about his stage four prostate cancer diagnosis, revealing that he "fell through the gaps" with early testing. Despite not having a national screening programme for prostate cancer due to the lack of a reliable test, Murnaghan encouraged men
